SSPL Securities Private Limited

Saturday 31 May, 2025 01:27 AM

SML Isuzu gains after Q4 PAT rises 1% YoY to Rs 53 cr Alembic Pharma receives USFDA final approval for Bosutinib tablets Dynamic Cables gains after board declares 1:1 bonus issue Samhi Hotels Q4 PAT jumps 306% YoY to Rs 46 cr Welspun Living Ltd leads losers in 'A' group Sobha gains after Q4 PAT soars 481% YoY to Rs 41 cr Kiri Industries Ltd leads losers in 'B' group SJVN slumps on reporting dismal Q4 PAT Crisil Ratings assigns 'A1+' rating to commercial paper of Muthoot Microfin Volumes soar at Gujarat Pipavav Port Ltd counter ICRA reaffirms ratings of Ethos at 'A+' with 'stable' outlook EFC (I) surges after PAT rises over 71% YoY in Q4; EBITDA margin at 51.8% Metal shares fall United Spirits Ltd down for fifth straight session KNR Constructions slides as Q4 PAT slumps 61% YoY to Rs 248 cr

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

Aurobindo Pharma arm incorporates WOS in Netherlands

29-May-25 08:40 Hrs IST

The purpose of the incorporation of this wholly owned subsidiary is to expand the biopharma products business in Europe.

The company has subscribed to an initial share capital of Euro 10,000, divided into 10,000 shares with a nominal value of Euro 1.00 each.

Aurobindo Pharma is an integrated global pharmaceutical company headquartered in Hyderabad, India. The company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries.

The company's consolidated net profit fell 0.6% to Rs 903.47 crore despite a 11.9% jump in net sales to Rs 8,381.12 crore in Q4 FY25 over Q4 FY24.

The scrip declined 3.61% to end at Rs 1,147.95 on the BSE.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 41219461

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)